Identification of synergistic drug combinations with the oral HSP90 inhibitor Debio 0932 in non-small cell lung cancer and renal cell cancer

被引：0
|
作者：
Langdon, Casey G. [1 ]
Wiedemann, Norbert [2 ]
Hajjami, Helene Maby-El [2 ]
Held, Mathew A. [1 ]
Platt, James T. [1 ]
Vuagniaux, Gregoire [2 ]
Bosenberg, Marcus W. [1 ]
Stern, David F. [1 ]
Levy, Frederic [2 ]
机构：
[1] Yale Univ, New Haven, CT USA
[2] Debiopharm Int SA, Lausanne, Switzerland
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-1792
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1792
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models
    David A. Proia
    Jim Sang
    Suqin He
    Donald L. Smith
    Manuel Sequeira
    Chaohua Zhang
    Yuan Liu
    Shuxia Ye
    Dan Zhou
    Ronald K. Blackman
    Kevin P. Foley
    Keizo Koya
    Yumiko Wada
    Investigational New Drugs, 2012, 30 : 2201 - 2209
  • [2] Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models
    Proia, David A.
    Sang, Jim
    He, Suqin
    Smith, Donald L.
    Sequeira, Manuel
    Zhang, Chaohua
    Liu, Yuan
    Ye, Shuxia
    Zhou, Dan
    Blackman, Ronald K.
    Foley, Kevin P.
    Koya, Keizo
    Wada, Yumiko
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (06) : 2201 - 2209
  • [3] Targeting KRAS-Mutant Non-Small Cell Lung Cancer with the Hsp90 Inhibitor Ganetespib
    Acquaviva, Jaime
    Smith, Donald L.
    Sang, Jim
    Friedland, Julie C.
    He, Suqin
    Sequeira, Manuel
    Zhang, Chaohua
    Wada, Yumiko
    Proia, David A.
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (12) : 2633 - 2643
  • [4] Defining Hsp90 as inhibitor of apoptosis in small cell lung cancer
    Chiosis, G.
    Rodina, A.
    Kim, J.
    Aguirre, J.
    Moulick, K.
    Lopes, E. Caldas
    Wu, N.
    She, Y.
    EJC SUPPLEMENTS, 2006, 4 (12): : 128 - 128
  • [5] Complex crystal structure determination and anti-non-small-cell lung cancer activity of the Hsp90N inhibitor Debio0932
    Qin, Wei
    Yu, Feng
    Zhou, Huan
    Li, Ping
    Zhou, Fang
    Li, Hui-Jin
    He, Chun-Xia
    Xing, Lu
    Zhou, Xin
    Zhao, Dong
    Li, Peng-Quan
    Jin, Xi
    Wang, Qi-Sheng
    He, Jian-Hua
    Cao, Hui-Ling
    ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2021, 77 : 86 - 97
  • [6] Comparative effectiveness analysis of HSP90 inhibitors in non-small cell lung cancer
    Marrugal, A.
    Ojeda Marquez, L.
    Quintanal, A.
    Molina-Pinelo, S.
    Ferrer, I.
    Carnero, A.
    Paz-Ares, L.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S63 - S64
  • [7] The HSP90 inhibitor ganetespib potentiates effect of ionizing radiation in human non-small cell lung cancer
    Casal, Roberto Gomez
    Bhattacharya, Chitralekha
    Epperly, Michael
    Socinski, Mark
    Levina, Vera
    CANCER RESEARCH, 2014, 74 (19)
  • [8] Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients
    Zhong, L
    Peng, XJ
    Hidalgo, GE
    Doherty, DE
    Stromberg, AJ
    Hirschowitz, EA
    CANCER DETECTION AND PREVENTION, 2003, 27 (04): : 285 - 290
  • [9] Effect of HSP90 inhibitor ganetespib on sternness in small cell lung cancer
    Gomez-Casal, Roberto
    Zhang, Peng
    Wang, Hong
    Gardner, Paul
    Herman, James
    Levina, Vera
    CANCER RESEARCH, 2016, 76
  • [10] A drug combination screen identifies taxanes as synergistic agents with the oral IAP inhibitor Debio 1143 in non-small cell lung cancer cells.
    Langdon, Casey G.
    Wiedemann, Norbert
    Held, Mathew A.
    Platt, James T.
    Levy, Frederic
    Zanna, Claudio
    Vuagniaux, Gregoire
    Sorensen, Mel
    Wang, Shaomeng
    Bosenberg, Marcus W.
    Stern, David F.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
12345